Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

H.G. Nusslein; R. Alten; M. Galeazzi; H.M. Lorenz; D. Boumpas; M.T. Nurmohamed; W.G. Bensen; G.R. Burmester; H.H. Peter; F. Rainer; K. Pavelka; M. Chartier; C. Poncet; C. Rauch; M. Le Bars

doi:10.1186/1471-2474-15-14

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

H.G. Nusslein, R. Alten, M. Galeazzi, H.M. Lorenz, D. Boumpas, M.T. Nurmohamed, W.G. Bensen, G.R. Burmester, H.H. Peter, F. Rainer, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	14
Journal	BMC Musculoskeletal Disorders
Volume	15
DOIs	https://doi.org/10.1186/1471-2474-15-14
Publication status	Published - 2014

Access to Document

10.1186/1471-2474-15-14

Cite this

Nusslein, H. G., Alten, R., Galeazzi, M., Lorenz, H. M., Boumpas, D., Nurmohamed, M. T., Bensen, W. G., Burmester, G. R., Peter, H. H., Rainer, F., Pavelka, K., Chartier, M., Poncet, C., Rauch, C., & Le Bars, M. (2014). Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study. BMC Musculoskeletal Disorders, 15, [14]. https://doi.org/10.1186/1471-2474-15-14

@article{337aea6ef1d44dcab16109f4e31b9361,

title = "Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study",

author = "H.G. Nusslein and R. Alten and M. Galeazzi and H.M. Lorenz and D. Boumpas and M.T. Nurmohamed and W.G. Bensen and G.R. Burmester and H.H. Peter and F. Rainer and K. Pavelka and M. Chartier and C. Poncet and C. Rauch and {Le Bars}, M.",

year = "2014",

doi = "10.1186/1471-2474-15-14",

language = "Undefined/Unknown",

volume = "15",

journal = "BMC Musculoskeletal Disorders",

issn = "1471-2474",

publisher = "BioMed Central",

}

Nusslein, HG, Alten, R, Galeazzi, M, Lorenz, HM, Boumpas, D, Nurmohamed, MT, Bensen, WG, Burmester, GR, Peter, HH, Rainer, F, Pavelka, K, Chartier, M, Poncet, C, Rauch, C & Le Bars, M 2014, 'Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study', BMC Musculoskeletal Disorders, vol. 15, 14. https://doi.org/10.1186/1471-2474-15-14

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study. / Nusslein, H.G.; Alten, R.; Galeazzi, M. et al.

In: BMC Musculoskeletal Disorders, Vol. 15, 14, 2014.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

AU - Nusslein, H.G.

AU - Alten, R.

AU - Galeazzi, M.

AU - Lorenz, H.M.

AU - Boumpas, D.

AU - Nurmohamed, M.T.

AU - Bensen, W.G.

AU - Burmester, G.R.

AU - Peter, H.H.

AU - Rainer, F.

AU - Pavelka, K.

AU - Chartier, M.

AU - Poncet, C.

AU - Rauch, C.

AU - Le Bars, M.

PY - 2014

Y1 - 2014

U2 - 10.1186/1471-2474-15-14

DO - 10.1186/1471-2474-15-14

M3 - Article

C2 - 24410774

VL - 15

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

SN - 1471-2474

M1 - 14

ER -